Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKB | Q96GD4 | 18/20 | 1.00 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.85 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.85 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.85 |
| ▸ | FLT3 | P36888 | 2/20 | 0.84 |
| ▸ | EPHB4 | P54760 | 2/20 | 0.84 |
| ▸ | LCK | P06239 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12588199 | 0.93 | AURKB (0.88) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13153153 | 0.92 | CHEK1 (1.00) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13153248 | 0.90 | CHEK1 (0.89) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL12588180 | 0.86 | CHEK1 (0.88) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13155484 | 0.85 | CHEK1 (0.85) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13983735 | 0.85 | CHEK1 (0.82) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL12588184 | 0.84 | CHEK1 (0.78) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13155431 | 0.84 | AURKB (0.79) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13983635 | 0.84 | AURKB (0.72) | AURKBCHEK1IRAK4RPS6KA3FLT3 | |
| SCHEMBL13155483 | 0.84 | CHEK1 (0.75) | AURKBCHEK1IRAK4RPS6KA3FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009137378-A2 | SEQUENTIAL ADMINISTRATION OF CHEMOTHERAPEUTIC AGENTS FOR TREATMENT OF CANCER | SCHERING CORPORATION (US) | 2009-11-12 | — | — | WO | disclosed |